Clinical trial

Clinical Trial for PB-119 in Healthy Subjects (Phase I)

NCT02084251

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-01

PhasePHASE1

Study timeline

Study start (unknown)2014-02-01Date precision: month

Registry last updated2017-02-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type II Diabetesunresolved

Interventions

PB-119DRUG

Sponsors & collaborators

PegBio Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02084251 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.